Key facts
- It has raised $2.8M; the latest was Later Stage VC in Sep 2025.
- Notable investors include SND Ventures Group, Tsinghua Innovation Ventures, Dalton Venture, LongRiver Investments.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Jingqin Zhizao
- ·The full record, as it builds
Funding rounds
No funding rounds for Jingqin Zhizao are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jingqin Zhizao
Developer of surgical instruments designed for the medical field. The company's products mainly focus on innovative technology research and development in the field of medical engineering, the company's "universal flexible transmission technology" can accurately convert the movement of the surgeon's hands, wrists, and arms from the movement outside the patient's body into the corresponding movement of the end effector inside the patient's body, enabling doctors to simplify dissection and suture of hard-to-reach target surgical areas.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2021
- Ownership
- Privately Held (backing)
Jingqin Zhizao doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jingqin Zhizao shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jingqin Zhizao in its N-PORT filings yet. We sweep new filings monthly.